Cargando…
Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers’ diarrhoea: reply
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509471/ https://www.ncbi.nlm.nih.gov/pubmed/30848824 http://dx.doi.org/10.1093/jtm/taz014 |
| _version_ | 1783417254814154752 |
|---|---|
| author | Steffen, Robert DuPont, Herbert L |
| author_facet | Steffen, Robert DuPont, Herbert L |
| author_sort | Steffen, Robert |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6509471 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65094712019-05-15 Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers’ diarrhoea: reply Steffen, Robert DuPont, Herbert L J Travel Med Correspondence Oxford University Press 2019-03-08 /pmc/articles/PMC6509471/ /pubmed/30848824 http://dx.doi.org/10.1093/jtm/taz014 Text en © International Society of Travel Medicine 2019. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Correspondence Steffen, Robert DuPont, Herbert L Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers’ diarrhoea: reply |
| title | Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers’ diarrhoea: reply |
| title_full | Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers’ diarrhoea: reply |
| title_fullStr | Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers’ diarrhoea: reply |
| title_full_unstemmed | Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers’ diarrhoea: reply |
| title_short | Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers’ diarrhoea: reply |
| title_sort | rifamycin sv-mmx® as the recommended self-treatment for moderate to severe travellers’ diarrhoea: reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509471/ https://www.ncbi.nlm.nih.gov/pubmed/30848824 http://dx.doi.org/10.1093/jtm/taz014 |
| work_keys_str_mv | AT steffenrobert rifamycinsvmmxastherecommendedselftreatmentformoderatetoseveretravellersdiarrhoeareply AT dupontherbertl rifamycinsvmmxastherecommendedselftreatmentformoderatetoseveretravellersdiarrhoeareply |